These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22908014)

  • 41. The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation.
    Chiu H; Mallya S; Nguyen P; Mai A; Jackson LV; Winkler DG; DiNitto JP; Brophy EE; McGovern K; Kutok JL; Fruman DA
    Front Immunol; 2017; 8():747. PubMed ID: 28713374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PI3K signaling controls cell fate at many points in B lymphocyte development and activation.
    Donahue AC; Fruman DA
    Semin Cell Dev Biol; 2004 Apr; 15(2):183-97. PubMed ID: 15209378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking.
    Mellor P; Furber LA; Nyarko JN; Anderson DH
    Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia.
    Herman SE; Lapalombella R; Gordon AL; Ramanunni A; Blum KA; Jones J; Zhang X; Lannutti BJ; Puri KD; Muthusamy N; Byrd JC; Johnson AJ
    Blood; 2011 Apr; 117(16):4323-7. PubMed ID: 21378270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.
    Jiang X; Chen S; Asara JM; Balk SP
    J Biol Chem; 2010 May; 285(20):14980-14989. PubMed ID: 20231295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
    Balakrishnan K; Peluso M; Fu M; Rosin NY; Burger JA; Wierda WG; Keating MJ; Faia K; O'Brien S; Kutok JL; Gandhi V
    Leukemia; 2015 Sep; 29(9):1811-22. PubMed ID: 25917267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
    Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
    Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK.
    Tran KB; Kolekar S; Jabed A; Jaynes P; Shih JH; Wang Q; Flanagan JU; Rewcastle GW; Baguley BC; Shepherd PR
    BMC Cancer; 2021 Feb; 21(1):136. PubMed ID: 33549048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway.
    Fukuda RI; Tsuchiya K; Suzuki K; Itoh K; Fujita J; Utsunomiya A; Tsuji T
    J Biol Chem; 2009 Jan; 284(5):2680-2689. PubMed ID: 19047050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase.
    Gold MR; Ingham RJ; McLeod SJ; Christian SL; Scheid MP; Duronio V; Santos L; Matsuuchi L
    Immunol Rev; 2000 Aug; 176():47-68. PubMed ID: 11043767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PI3K/PTEN signaling in angiogenesis and tumorigenesis.
    Jiang BH; Liu LZ
    Adv Cancer Res; 2009; 102():19-65. PubMed ID: 19595306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.
    Moody JL; Jirik FR
    Immunology; 2004 Jul; 112(3):404-12. PubMed ID: 15196208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway.
    Getahun A; Wemlinger SM; Rudra P; Santiago ML; van Dyk LF; Cambier JC
    J Exp Med; 2017 Apr; 214(4):931-941. PubMed ID: 28341640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer.
    Condé C; Gloire G; Piette J
    Biochem Pharmacol; 2011 Nov; 82(10):1320-34. PubMed ID: 21672530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.
    Wiestner A
    Haematologica; 2015 Dec; 100(12):1495-507. PubMed ID: 26628631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.
    Chen Z; Getahun A; Chen X; Dollin Y; Cambier JC; Wang JH
    J Immunol; 2015 Dec; 195(11):5461-5471. PubMed ID: 26500350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.